ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors

Detalles Bibliográficos
Autores principales: Orentas, Rimas J, Lopomo, Paola, Babbitt, William, Vigny, Marc, Mackall, Crystal L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990339/
http://dx.doi.org/10.1186/2051-1426-1-S1-P27
_version_ 1782312263424671744
author Orentas, Rimas J
Lopomo, Paola
Babbitt, William
Vigny, Marc
Mackall, Crystal L
author_facet Orentas, Rimas J
Lopomo, Paola
Babbitt, William
Vigny, Marc
Mackall, Crystal L
author_sort Orentas, Rimas J
collection PubMed
description
format Online
Article
Text
id pubmed-3990339
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39903392014-05-01 ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors Orentas, Rimas J Lopomo, Paola Babbitt, William Vigny, Marc Mackall, Crystal L J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3990339/ http://dx.doi.org/10.1186/2051-1426-1-S1-P27 Text en Copyright © 2013 Orentas et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Orentas, Rimas J
Lopomo, Paola
Babbitt, William
Vigny, Marc
Mackall, Crystal L
ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors
title ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors
title_full ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors
title_fullStr ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors
title_full_unstemmed ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors
title_short ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors
title_sort alk (anaplastic lymphoma kinase, cd246)-specific cars: new immunotherapeutic agents for the treatment of pediatric solid tumors
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990339/
http://dx.doi.org/10.1186/2051-1426-1-S1-P27
work_keys_str_mv AT orentasrimasj alkanaplasticlymphomakinasecd246specificcarsnewimmunotherapeuticagentsforthetreatmentofpediatricsolidtumors
AT lopomopaola alkanaplasticlymphomakinasecd246specificcarsnewimmunotherapeuticagentsforthetreatmentofpediatricsolidtumors
AT babbittwilliam alkanaplasticlymphomakinasecd246specificcarsnewimmunotherapeuticagentsforthetreatmentofpediatricsolidtumors
AT vignymarc alkanaplasticlymphomakinasecd246specificcarsnewimmunotherapeuticagentsforthetreatmentofpediatricsolidtumors
AT mackallcrystall alkanaplasticlymphomakinasecd246specificcarsnewimmunotherapeuticagentsforthetreatmentofpediatricsolidtumors

Ejemplares similares